Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

NCT01076543

Conditions
AIDS-Related Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +27 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

NCT02268045

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hosp. Interzonal "R" Carrillo Ciudadela, Bariloche, Argentina
  • Clinica Radiologica del Sur Cipolletti, Río Negro Province, Argentina
  • Clinica Viedma Viedma, Río Negro Province, Argentina
  • Hospital Britanico Buenos Aires, Argentina
View all 87 locations
View Trial Details
Completed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00005799

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • University of Colorado Denver, Colorado, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details
Completed

Open-Label, Non Randomized Phase 2 Study With Safety Run-In

NCT02249429

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Weill Cornell Medicine New York, United States
  • University Clinical Center Republic of Srpska Banja Luka, Bosnia and Herzegovina
  • University Clinical Center Sarajevo Sarajevo, Bosnia and Herzegovina
  • Insitute Curie Saint-Cloud, Paris, France
View Trial Details
Completed

Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL

NCT00369707

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Hematology-Oncology Associates of Illinois Chicago, Illinois, United States
  • Northwestern University Chicago, Illinois, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions